Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0006271 (
bronchiolitis
)
5,174
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Each year
influenza
viruses are responsible for epidemic respiratory diseases with excess morbidity and mortality. The severity of
influenza
diseases ranges from mild upper respiratory tract infections to severe lower respiratory tract infections involving pneumonia,
bronchiolitis
and coincidental bacterial super-infections. The immune response to
influenza
viruses can be schematically divided into a cascade of non-specific and specific functions. These functions are involved at different well defined time points after infection. We describe in this manuscript three
influenza
models utilized in our laboratory: (i) a highly virulent
influenza
virus (
influenza
A/Hong Kong/8/68 (H3N2) virus) adapted to B6C3F1 mice, (ii) a mouse-adapted
influenza
A/Port Chalmers/1/73 (H3N2) virus, and (iii) a rat-adapted
influenza
virus (RAIV) model (
influenza
A/Port Chalmers/1/73 (H3N2)). This rat-adapted
influenza
model has been mainly utilized as a model to assess local immunotoxic effects of inhaled environmental pollutants such as phosgene. These host resistance models are also useful for assessing the effect of systemically-induced immunosuppression or immunomodulation by drugs or chemicals on the local pulmonary immune response to
influenza
virus. The comparison of these different models allowed two major conclusions: (a) viral replication and mortality are two different endpoints and are not necessarily linked (no mortality was observed with Port Chalmers virus in the mouse although the virus replicates to high titers in the lung with a kinetic pattern comparable to the one obtained with Hong Kong virus), (b) mortality, viral replication, and immune function assessment are different endpoints that can be used, depending on the question addressed.
...
PMID:Influenza virus host resistance models in mice and rats: utilization for immune function assessment and immunotoxicology. 805 41
Eosinophil cationic protein (ECP) was assayed in nasopharyngeal secretion (NPS) and serum from 42 infants, hospitalized with acute lower respiratory infection, in El Salvador and the results analyzed in relation to etiology of the infection. ECP concentrations were high in NPS, at an average 50 times higher than those found in serum. Exceedingly high levels of ECP (> 1000 micrograms/L) were found more frequently in wheezing than in non-wheezing children (30% vs 7%) and, accordingly, were more commonly found in children hospitalized with
bronchiolitis
than in those with pneumonia. Excessive levels were significantly more common in girls than in boys. Of the 42 cases, 28 were found to be caused by respiratory syncytial virus (RSV) subgroup A, and 3 by RSV-B, by means of detection of RSV antigen in nasopharyngeal cells. ECP serum levels were moderately elevated during the acute phase of the respiratory infection and increased slightly but significantly, in cases with RSV antigen-positive
bronchiolitis
, but not in those with pneumonia. The ECP levels in NPS from patients in Sweden who, by antigen detection in NPS cells, were diagnosed as either RSV or para-
influenza
3 infection or none of these, were similar. These results indicate that elevation of ECP in NPS is associated with acute lower respiratory infection in general, but particularly pronounced in cases of
bronchiolitis
. Elevation of ECP is not an exclusive consequence of RSV infection, but may occur to an equal extent in infections caused by other agents.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Eosinophil cationic protein in nasopharyngeal secretions and serum of infants infected with respiratory syncytial virus. 808 88
Most histopathologic descriptions of
influenza
pneumonia are based on autopsy findings in fatal cases during epidemics and pandemics of
influenza
. We describe the histologic findings of
influenza
pneumonia observed in biopsy material derived from six sporadic cases of
influenza
(
influenza
A, four cases;
influenza
B, one case; and
influenza
A and B, one case). Four patients recovered completely, one patient died, and one was lost to follow-up. In addition to confirming previously published pathologic descriptions of
influenza
pneumonia, we also document a spectrum of less severe histologic findings with mild acute lung injury and
bronchiolitis
obliterans with organizing pneumonia.
...
PMID:Pathologic features of lung biopsy specimens from influenza pneumonia cases. 831 60
Under an
influenza
surveillance initiated in Pune, India, 2 or 3 dispensaries and small hospitals where patients with acute respiratory disease (ARD) sought medical assistance were chosen for regular weekly visits to collect a sufficient number of specimens. A case of ARD included individuals with the following conditions: common cold, pharyngitis, laryngitis, tracheitis, bronchitis,
bronchiolitis
, pneumonia, or bronchopneumonia. During the period of surveillance of 1978-90, more than 10,000 cases of ARD among various age groups were investigated. The majority of cases were in children and infants. Most of the patients were seen during investigations of 16 outbreaks of
influenza
. Generally, the cases presented with 2 or 3 symptoms of respiratory disease and 1 or 2 systemic manifestations. Throat and nasal swabs were collected from ARD cases during the acute phase of their illness (1-4 days). Throat/nasal swabs were taken from over 10,000 ARD cases. About 80% of these specimens were cultivated for
influenza
virus in embryonated chicken eggs (9-11 days' old) and about 39% in Madin-Darby canine kidney cell culture (MDCK) with crystalline trypsin. Several variants of
influenza
virus types A and B were isolated during the 16 outbreaks including these variant strains: A/USSR/77 (H1N1) in 1978; A/Singapore/6/86 (H1N1) in 1986; and B/Yamagata/16/88-like in 1990. A total of 290
influenza
virus isolates comprising several variants of
influenza
type A (H3N2) and A (H1N1) and type B were isolated. The variant strains of
influenza
type A (H1N1), type A (H3N2), and type B circulated regularly either every year or in alternate years. 181 of 290 of the
influenza
isolates were from children aged 10 years. Analysis of the isolates showed that 174 were from the rainy months of July, August, and September, and the maximum number of 93 occurred in July. Of the 16 outbreaks of
influenza
, 10 occurred in the rainy season, 3 in the hot season, 1 in the cool season, and 2 in February and March.
...
PMID:Influenza surveillance in Pune, India, 1978-90. 849 Sep 80
In a prospective study of acute lower respiratory infections (ALRI), at the University College Hospital, UCH, Ibadan, 35 viral pathogens were identified by immunofluorescence (IF) techniques from 24 (68.6%) respiratory specimens from 35 hospitalised pre-school children. The respiratory diagnoses comprised croup,
bronchiolitis
, pneumonia and pleural effusion. The viral identifications comprised 14 (40.0%) of parainfluenza virus type 3, 10 (28.6%) of respiratory syncytial virus (RSV), 5 (14.3%) of
influenza
virus type A, 4 (11.4%) of parainfluenza virus type 1 and 2 (5.7%) of
influenza
virus type B. Two or more viral agents were identified in as many as 10 (41.7%) of the 24 IF positive secretions, 8 (80.0%) of which were obtained from children with features of protein energy malnutrition. Twenty subjects had both virological and bacteriological analyses, in 8 (40.0%) of whom co-existing bacteraemia was identified. Four (50.0%) of these blood culture positive subjects, also had features of overt malnutrition. Neither the age nor the sex was significantly related to the viral identifications (P > 0.81 & 0.35 respectively). Similarly, the final respiratory diagnoses were not significantly related to the viral identifications despite the seemingly suggestive relationship between a diagnosis of croup and parainfluenza identifications as well as that between pneumonia and RSV/parainfluenza type 3 identifications. It is concluded that the high proportion of positive viral identifications is a pointer to the importance of viruses as possible primary etiological agents of ALRI in countries of the West African sub-region and perhaps in developing countries of other tropical subregions. The multiplicity of microbial identifications (viruses and bacteria), seen in malnourished children, may explain the clinical severity of ALRI in the same group of children. The usefulness of IF as a rapid diagnostic tool, as well as the potential implications of our findings on ARI control in developing countries, are discussed.
...
PMID:Viral pathogens of acute lower respiratory infections in pre-school Nigerian children and clinical implications of multiple microbial identifications. 851 76
This report summarises the information obtained by surveillance of
influenza
in England and Wales from October 1994 to June 1995 (weeks 40/94 to 25/95).
Influenza
B viruses were responsible for most infections, with moderate activity occurring throughout the winter, peaking in February.
Influenza
A became more active towards the end of the winter, and laboratory reports reached a peak in May (week 21/95).
Influenza
activity was seen first in Wales, then England, followed by Scotland. An increase in 'total respiratory disease' was reported in December 1994 by the Birmingham Research Unit of the Royal College of General Practitioners (RCGP) in England and Wales. This was probably due largely to an increase in reports of acute bronchitis, and was concurrent with the annual increase in respiratory syncytial virus infection which is often associated with
bronchiolitis
. Circulating
influenza
viruses were antigenically similar to components of the vaccine chosen for 1994/95. This report summarises the recommendations for the 1995/96
influenza
vaccine.
...
PMID:Influenza surveillance in England and Wales: October 1994 to June 1995. 855 5
Viral etiologic agents of acute lower respiratory tract infections were studied from November, 1990, through April, 1994, in Korean children. From 712 children who visited or were admitted to Seoul National University Children's Hospital because of acute lower respiratory tract infections, 804 nasal aspirates were collected; viral agents were detected by virus isolation and virus antigen was detected by indirect immunofluorescent staining. One or more viral agents were identified in 369 (45.9%) cases; of which 3.3% were mixed infections. The pathogens identified were respiratory syncytial virus (27.2%), parainfluenza virus type 3 (7.8%),
influenza
A virus (3.9%), adenovirus (3.9%), parainfluenza virus type 1 (1.7%),
influenza
B virus (1.4%), parainfluenza virus type 2 (0.5%), measles virus (0.1%) and others (0.9%). The clinical patterns of viral lower respiratory tract included pneumonia (56.6%),
bronchiolitis
(35.2%), croup (6.5%) and tracheo-bronchitis (1.6%). Infections with respiratory syncytial virus, parainfluenza virus types 1 and 3 and
influenza
A and B virus occurred in epidemics, whereas adenovirus was isolated sporadically throughout the study period. The data expand our understanding of the epidemiology of acute viral lower respiratory tract infections in Korean children and may be helpful to the clinicians and researchers interested in the control of viral respiratory tract infections.
...
PMID:Viral etiology and epidemiology of acute lower respiratory tract infections in Korean children. 874 17
Viral lower respiratory tract infections continue to cause a great deal of morbidity and mortality in the United States and worldwide, despite advances in treatment options, chemoprophylaxis, and vaccine development. The availability of ribavirin has improved the outlook in high-risk patients who develop respiratory syncytial virus
bronchiolitis
while intensive efforts are continued to develop an efficacious and safe vaccine. Respiratory syncytial virus immunoglobulin may prove to be a useful tool in the armamentarium of the pediatrician to prevent or modify respiratory syncytial virus disease in individual patients.
Influenza
vaccination and chemoprophylaxis remain mainstays in the prevention of
influenza
disease in high-risk individuals. The availability of a vaccine for varicella and a wider dissemination of measles vaccine, particularly in developing nations, may well limit the adverse outcomes associated with pneumonias caused by these two viruses. The transplant patient and other immunocompromised patients will continue to challenge clinicians and scientists to provide innovative and effective therapies for viral infections. The exciting advances in clinical and research virology over the last decade offer much hope to practicing pediatricians who struggle with offering prevention strategies and treatment options for their patients. Viral lower respiratory tract infections will never be eliminated as a clinical problem, although the morbidity and mortality associated with them will continue to improve.
...
PMID:Common (but not always considered) viral infections of the lower respiratory tract. 890 69
Nasal swab from patients with acute
flu
-like illness were evaluated for the presence of respiratory viruses in the Rhone-Alpes region of France from 1 October 1994 through 2 May 1995. The relative frequencies and seasonal distributions of the specific viruses were assessed. In addition, virus type was correlated with specific clinical signs and symptoms. During the study, 962 samples were collected by 75 medical practitioners participating in the Groupe Regional d'Observation de la
Grippe
surveillance network. One or more viruses were detected from 348 samples (36.1%), including 108 respiratory syncytial virus (RSV), 64
influenza
virus A type H3N2, 47
influenza
virus B, 64 coronavirus, 35 rhinovirus, 22 adenovirus, 5 enterovirus, and 3 parainfluenza-fluenza strains. There were 16 mixed infections. RSV infections peaked in the early winter, and
influenza
viruses A and B infections peaked during the late winter and early spring. There were two peaks of coronavirus infections (late fall and late winter). Other viruses were detected at lower levels throughout the study period. Patients from whom adenovirus was isolated were significantly more likely to have a fever of > 39.5 degrees C than were patients with other detectable viruses (P < 0.001). Furthermore, there was a significant correlation between
influenza
and cough (P < 0.01) and RSV and
bronchiolitis
(P < .001). Thus, the current study defined the overall and relative frequencies of respiratory virus detection from nasal swab specimens in patients with an acute
flu
-like illness in the Rhone-Alpes region of France during a 7-month period. Correlation with clinical signs and symptoms and provisional conclusions regarding seasonality were also determined.
...
PMID:Surveillance of community-acquired viral infections due to respiratory viruses in Rhone-Alpes (France) during winter 1994 to 1995. 894 Apr 39
This report summarises information collected for the surveillance of
influenza
virus infection in England and Wales from October 1995 to June 1996 (weeks 40/95 to 25/96). Total respiratory disease' activity, as reported by the Birmingham Research Unit of the Royal College of General Practitioners, rose to peaks in weeks 48/95, 51/95, and 01/96. The first peak coincided with a peak in "influenza and
flu
-like illness'. The subsequent peaks were accounted for by an increase in reports of acute bronchitis, including
bronchiolitis
, and may have been associated with the annual rise in infections with respiratory syncytial virus.
Influenza
A virus was responsible for most infections, with moderate activity occurring in the early part of the winter, peaking in December (week 48/95).
Influenza
A subtype H3N2 predominated until week 07/96, after which subtype H1N1 accounted for most infections.
Influenza
activity was first seen in central and northern England, followed by the south of England, Wales, and Scotland. Circulating
influenza
viruses were antigenically similar to the components of the 1995/96 vaccine. International surveillance during 1995/96 has led to a different H3N2 component being included in the
influenza
vaccine recommended for 1996/97.
...
PMID:Influenza surveillance in England and Wales: October 1995 to June 1996. 897 79
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>